Interestingly, silencing CCAT2 with small interfering RNA (siRNA) inhibited invasion and proliferation in NSCLC cell lines in vitro, and CCAT2 over-expression was substantially associated with LAD but not LSCC. Here, CCAT2 is linked to non-small cell lung carcinoma.